Top Markets
Coin of the day
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Classificação em ações #34062
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Preço da ação
$0.223
Última sincronização: 2026-08-14
Valor de mercado
$6.32M
Variação (1 dia)
1.64%
Variação (1 ano)
-
País
US
Negociar Curanex Pharmaceuticals Inc Common Stock (CURX)

Categoria

EPS de Curanex Pharmaceuticals Inc Common Stock (CURX)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Curanex Pharmaceuticals Inc Common Stock, o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Curanex Pharmaceuticals Inc Common Stock de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE